Asthma: New Research Shows That Asthma Is Not A Risk Factor Of Increased Severity Of COVID-19
: According to a new research by scientist from University of St Vincent in Ireland, individuals with asthma are not at a higher risk of developing more severe conditions of COVID-19 as research findings show that the condition does not increase one’s risk of hospitalization when contracting the coronavirus.
The study findings were published in the Journal of Allergy and Clinical Immunology
A detailed review of records from 10 hospitals affiliated with Northwestern Medicine turned up more than 1,500 patients with COVID-19. Of these, only 14% had asthma.
Utilizing models that accounted for age, sex and ethnicity while adjusting for asthma risk factors such as smoking and obesity, the investigators found no meaningful difference in odds of hospitalization between individuals with and without asthma.
Furthermore, the use of asthma medications such as inhaled corticosteroids and long-acting beta-agonists did not increase hospitalization risk. According to the research findings, the researchers found that asthma did not lead to more deaths from the COVID-19 disease.
Dr Anju Peters, a Professor of medicine at Northwestern Feinberg School of Medicine in Chicago told Thailand Medical News, "We would usually expect for asthmatic patients to have worse outcomes, as viral illness often can set off asthma exacerbations.”
Dr Peters further added, "More studies must be done to look at the underlying immune modulation caused by asthma or asthma treatment to see what impact it may have on COVID-19 outcomes.”
For more about Asthma
and COVID-19, keep on logging to Thailand Medical News.